Skip to main content
European Commission logo print header
Contenido archivado el 2024-04-19

Comparison and harmonisation of screening and confirmatory methods for the determination of beta-agonists

Objetivo



The objective of this project is to develop and validate a number of new screening (functional test beta-agonists (FTBA), EIA/ractopamine&fenoterol, GC-MS) and confirmatory procedures (LC-MS-MS) for a large range of beta-agonists. The validation also comprises an intercomparison study to correlate the performance of the new procedures with currently used procedures. The work programme contains two main parts. The first part will involve the development and validation of a number of new screening (functional test beta-agonists (FTBA), EIA/ractopamine&fenoterol, GC-MS) and confirmatory procedures (LC-MS-MS) for a large range of beta-agonists. In the second part, an intercomparison study will be carried out in order to validate the procedures and to determine the performance characteristics (false positive and false negative results) compared to currently used procedures.

Tema(s)

Data not available

Convocatoria de propuestas

Data not available

Régimen de financiación

CSC - Cost-sharing contracts

Coordinador

STATE INSTITUTE FOR QUALITY CONTROL OF AGRICULTURAL PRODUCTS (RIKILT)
Aportación de la UE
Sin datos
Dirección
Bornsesteeg 45
6708 PD WAGENINGEN
Países Bajos

Ver en el mapa

Coste total
Sin datos

Participantes (6)